It alleviated joint inflammation and reduced paw edema. Infliximab improved the trabecular microstructure and reversed the tendinopathy induced by collagen-induced arthritis (CIA). The levels of TNF-α and IL-23 significantly decreased. Here, TNF is linked to inflammatory response.